Atomoxetine treatment for ADHD: Younger adults compared with older adults

Journal of Attention Disorders

Volumn 13, Issue 4, 2010, Pages 401-406

  Durell, Todd ^a   Adler, Lenard ^b   Wilens, Timothy ^c   Paczkowski, Martin ^a   Schuh, Kory ^a  

^a ELI LILLY AND COMPANY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

ADHD; Adult; Atomoxetine; Attention deficit hyperactivity disorder

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; ATOMOXETINE; PROPYLAMINE;

ADOLESCENT; ADULT; AGE; ARTICLE; ATTENTION DEFICIT DISORDER; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; META ANALYSIS; MIDDLE AGED; TREATMENT OUTCOME;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; AGE FACTORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPYLAMINES; TREATMENT OUTCOME;

EID: 72149083305     PISSN: 10870547     EISSN: 15571246     Source Type: Journal    
DOI: 10.1177/1087054709342203     Document Type: Article

References (14)

1. Adler, L., Brown, T.E., Holdnack, J., Saylor, K., Paczkowski, M., Schuh, K.,et al.(2007, October). Once-daily atomoxetine for adult ADHD: A 6-month, double-blind trial. Poster session presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting, Boston, MA.
2. Adler, L., Dietrich, A., Reimherr, F.W., Taylor, L.V.M., Sutton, V.K., Bakken, R.,et al.(2006). Safety and tolerability of once versus twice daily atomoxetine in adults with ADHD. Annals of Clinical Psychiatry, 18, 107-113.
3. Adler, L.A., Spencer, T.J., Levine, L.R., Ramsey, J.L., Tamura, R., Kelsey, D.,et al.(2008). Functional outcomes in the treatment of adults with ADHD. Journal of Attention Disorders, 11, 720-727.
4. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: Author.
5. Barkley, R.A. (2002). Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 63(Suppl. 12), 10-15.
6. Barkley, R.A., Murphy, K.R., & DuPaul, G.R. (2002). Driving in young adults with attention deficit hyperactivity disorder: Knowledge, performance, adverse outcomes and the role of executive functions. Journal of the International Neuropsychological Society, 8, 655-672.
7. Barkley, R.A., Murphy, K.R., & Kwasnik, D. (1996). Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics, 98, 1089-1095.
8. Conners, C.K., Erhardt, D., & Sparrow, E. (1999). Conners' Adult ADHD Rating Scales (CAARS). North Tonawanda, NY: Multi-Health Systems.
9. Guy, W. (1976). ECDEU assessment manual for psychopharmacology revised. Bethesda, MD: United States Department of Health Education and Welfare.
10. Kessler, R.C., Adler, L., Barkley, R., Biederman, J., Conners, C.K., Demler, O.,et al.(2006). The prevalence and correlates of adult ADHD in the United States: Results from the national comorbidity survey replication. American Journal of Psychiatry, 163, 716-723.
11. Mannuzza, S., & Klein, R.G. (2000). Long-term prognosis in attention-deficit hyperactivity disorder. Child and Adolescent Psychiatric Clinics of North America, 9, 711-726.
12. Michelson, D., Adler, L., Spencer, T., Reimherr, F., West, S., Allen, A.,et al.(2003). Atomoxetine in adults with ADHD: Two randomized, placebo-controlled studies. Biological Psychiatry, 53, 112-120.
13. Secnik, K., Swensen, A., & Lage, M. (2005). Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder. Pharmacoeconomic, 23, 93-102.
14. Wender, P.H., Wolf, L.E., & Waserstein, J. (2001). Adults with ADHD: An overview. Annals of the New York Academy of Sciences, 931, 1-6.